Aberrant signaling pathways in glioma. - Wikidata - awgldk - TriplyDB

Aberrant signaling pathways in glioma.

Aberrant signaling pathways in glioma.

http://www.wikidata.org/entity/Q38161369

about

Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme.Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).RasGRP3 regulates the migration of glioma cells via interaction with Arp3 Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling.Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.Mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma.Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade Astrocytoma Effect of Necrosis on the miRNA-mRNA Regulatory Network in CRT-MG Human Astroglioma Cells.LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair (MMR) pathway Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.The mechanistic influence of aligned nanofibers on cell shape, migration and blebbing dynamics of glioma cells.Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme.Viability reduction and Rac1 gene downregulation of heterogeneous ex-vivo glioma acute slice infected by the oncolytic Newcastle disease virus strain V4UPM Apoptosis in glioma-bearing rats after neural stem cell transplantation.IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells.Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma.Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.The biology and mathematical modelling of glioma invasion: a review.mTOR-Dependent Cell Proliferation in the Brain.PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.Oxytocin mediates the beneficial effects of the exercise training on breast cancer.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.

P2860

Q26865911-8CF43A62-F24C-4B92-B950-D7E7662F2BC1 Q33829335-138C6FE8-4D74-44A7-9E35-9FE83BB85DA5 Q34704811-B58FCCC8-9515-4B1B-9340-0C9BFA9795E5 Q35027553-925E0A2C-D52F-4ABC-9CEF-EB48A49F7EE1 Q35176456-AA293266-BCB8-4335-9416-1677AEDA964D Q35748107-F74ECBA9-F3F4-4FF6-BC55-3E1676DB5D63 Q35870174-E7D18691-8CF6-4CF3-B3A5-033989913C6F Q35964637-2E226881-CB1B-486E-A9D3-0236D206A04A Q36500396-466E6CD5-9C75-4A6F-B51C-E3E2A26D06C1 Q36544237-EA5E3DB3-F3C0-4101-BD1A-CDFC24FEFB8C Q36782617-8334AED1-E137-424C-BEA5-C59C6A433486 Q36946655-7B273BAF-35BC-4360-BC5C-6C84EC4FE900 Q36953938-8E525511-D45C-4616-BF8A-C500E81F5FD3 Q38176547-5223B491-44D3-4D73-ADDB-0672E72ADAB3 Q38253056-B6FF39D1-7CDB-4075-8013-7A9B8599F6B8 Q38432528-8BCD5723-FEB8-4767-883F-BB399436E233 Q38433156-DF30633B-E3E0-4ED7-8D42-E5675CF94A2D Q38613368-C40C594A-AE27-4C1D-8446-E553CCB58F89 Q38743138-7E8B66FD-BC52-4B05-8442-3B02E41DC128 Q38929199-5D928ED5-1BDB-495D-BB80-87E7828A40AD Q39131998-19B6FF4F-CB9B-4090-9FAD-C4C31C98D06B Q39152200-9BBF07AE-C28A-45DE-BE4E-94D50076ACEB Q41135067-AC183B4C-D332-4238-894A-A4327D9DE439 Q41481825-DB79D758-5449-4753-85F4-187B916FFD33 Q41976320-0E2C5F58-CA9D-4767-8F85-62D6DBB29614 Q42844625-761DD779-E3B8-420A-ADE3-CD678686ACEC Q45794856-C28428E8-9114-4FAF-A59C-555C6BC1BDFC Q45802577-5394A1CB-93BC-46CD-A352-84E11D8873E0 Q46346861-D1E0563B-C5F1-4469-BA54-5B32D0FE3AE3 Q47115276-D2656BE4-FB2D-4B12-9513-50A14E6EA012 Q47124238-A5081F2D-7BFF-4D28-8312-5D8BE4FADF38 Q47231432-527F8CD4-9960-4508-9B32-3AE6D052F98E Q47588695-9C979542-F35C-40F2-8FAF-41BD72CD3EBB Q48292740-C32CEAFC-7649-402B-9784-26DF48EAF886 Q52366335-141770F3-05FA-432A-A33E-8613397EE59C Q52590668-A24BDFAC-4CEF-4871-9556-454B71421FFB Q52676604-73A72678-A3F0-4FDC-8869-99F0F317258D Q55457391-0ADC8040-0163-4E2E-B412-27EFB0AE7613

P2860

Aberrant signaling pathways in glioma.

http://www.wikidata.org/entity/Q38161369

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Aberrant signaling pathways in glioma.

@en

type

label

Aberrant signaling pathways in glioma.

@en

prefLabel

Aberrant signaling pathways in glioma.

@en

P1433

Q38161369-ECD27A4B-65C7-4AF7-B291-CA7ACB66867A

P1476

Q38161369-C8CA0271-C458-41F8-B3E7-D878C1FC5DCB

P2093

Q38161369-1AEB82E3-A16E-41DE-B091-259F3E6C5FBC

Q38161369-58140B3C-6C25-46E7-BAAE-2790E5AD39B6

Q38161369-8BE84890-74A7-4871-AB0D-795589D40269

Q38161369-AC971075-6771-42D5-A7CD-F48E64A8544C

Q38161369-F11EC97D-561C-4798-A7E0-E85C34A623F5

Q38161369-F42FBFA5-CAB2-4271-9482-71EAA017ED59

P2860

Q38161369-01044813-EA44-498B-885A-5D168B9606D5

Q38161369-015C8D18-2B95-453E-8C98-9E2AB7828F03

Q38161369-017AAA47-4E2C-4EED-B1A7-B62BDF8D37AB

Q38161369-04EB5780-172A-4C96-A7A8-E7E0003F0AB3

Q38161369-05077B93-C00C-471B-9FD8-AF1F486F5B25

Q38161369-055589BE-13AA-4A81-8BA4-C6AB04A99D23

Q38161369-06D27813-4D5E-472A-865E-BD50E1AD3554

Q38161369-073A3A38-A713-4164-9791-FC2D40E8EF84

Q38161369-0844120E-B639-47B3-A37D-096F1E556D30

Q38161369-0A8E8820-80FA-464F-B228-4BEC4D79B184

P304

Q38161369-6263B08A-7F67-48C9-B2F7-CE794F64C92C

P31

Q38161369-1E5D8544-EA96-41A5-A409-CBBF025B6E0A

P356

Q38161369-F10CA0C8-C79D-4E6F-AC36-44A4031E0B54

P433

Q38161369-76DFF49E-98D6-4412-85FC-DC638C2D3859

P478

Q38161369-5CAA936D-66A1-40A5-80EB-318CFEF699B2

P50

Q38161369-E5FD3E1E-9B13-4397-B39A-D97623F9AB3A

P577

Q38161369-D47CEF75-0B8D-40C3-B17A-51C822CA6860

P5875

Q38161369-86A37366-E454-41AC-B4CA-811DA34A69E4

P698

Q38161369-500FA61D-C6E2-4FB7-92C2-25BBD41DDAF7

P932

Q38161369-A265ABA2-7777-4159-8A0A-8726E3759C4B

P356

P1433

P1476

Aberrant signaling pathways in glioma

@en

P2093

Daisuke Kita

http://www.w3.org/2001/XMLSchema#string

Jun-Ichiro Hamada

http://www.w3.org/2001/XMLSchema#string

Lei Teng

http://www.w3.org/2001/XMLSchema#string

Mitsutoshi Nakada

http://www.w3.org/2001/XMLSchema#string

Takuya Watanabe

http://www.w3.org/2001/XMLSchema#string

Yutaka Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells

Development of NG2 neural progenitor cells requires Olig gene function

Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival

Cancerous stem cells can arise from pediatric brain tumors

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

IDH1 and IDH2 mutations in gliomas

P304

3242-3278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS3033242

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258429766

http://www.w3.org/2001/XMLSchema#string

P698

24212955

http://www.w3.org/2001/XMLSchema#string

P932

3759196

http://www.w3.org/2001/XMLSchema#string